Insights
Ideas and perspectives from Helmsley and our partners
Ideas and perspectives from Helmsley and our partners
November 18, 2026
Many people living with diabetes generate health information through continuous glucose monitoring systems, automated insulin delivery systems, and other connected devices. But data alone does not improve outcomes — to fully realize the benefits from this data, it needs to be interpreted, actionable, and incorporated into existing healthcare workflows.
November 17, 2026
In 2025 alone, more than 600,000 people died from undiagnosed type 1 diabetes (T1D) — people who never had the chance to receive the treatment and care they needed. This World Diabetes Day, the theme of early action underscores the importance of early detection and uninterrupted access to lifelong care. This year, early action has a new engine worth celebrating:…
November 14, 2026
Every year on World Diabetes Day, Helmsley partners with the Empire State Building and the Helmsley Building to light the New York City skyline blue and raise awareness about type 1 diabetes (T1D). This tradition reflects our commitment to helping the global T1D community live safer, better, and more fulfilling lives. As we reflect on this day where the diabetes…
November 12, 2026
For many of us, oxygen is just part of the air we breathe—something we take for granted. But for patients all over the world who have severe diseases or undergo surgery, medical oxygen is essential to their treatment and access remains a challenge. Today, on World Pneumonia Day, we must confront a stark reality: pneumonia remains the leading infectious cause…
October 28, 2026
Heather Barr wasn’t a first-time mom, so when she brought her infant daughter, Sophia, to Watford City, North Dakota, in June for the baby’s second-week checkup, she expected it to be a routine visit. But when Dr. Waco Goodnight placed his stethoscope near the baby’s heart, the pediatrician noticed a murmur that had grown significantly louder than the one he heard…
October 7, 2026
Looking back at the past 10 years, the progress in early detection of type 1 diabetes (T1D) and disease-modifying interventions has been amazing — especially the momentum in the past few years. Hundreds of thousands of children have been screened around the world. The first FDA-approved therapy to delay disease onset is available. Consensus guidance for autoantibody screening and monitoring…
September 16, 2026
We sat down with Sidhartha Sinha, MD, Assistant Professor of Medicine in Gastroenterology and Hepatology at Stanford University, to discuss his work evaluating the potential for the statin drug class, commonly prescribed to lower low-density lipoprotein (LDL or “bad cholesterol”), to treat stricturing Crohn’s disease. Strictures are narrowed areas of the intestine caused by inflammation and tissue thickening, and they…
September 1, 2026
A vial of insulin sitting in a drawer saves no one; in the hands of a clinic that has run out, it saves a life. Insulin for Life USA exists to close that gap by collecting donated, unopened insulin and diabetes supplies and redistributing them to clinics in low- and middle-income countries, under-resourced communities across the United States, and disaster…
August 5, 2026
Type 1 diabetes (T1D) is a lifelong condition that requires constant attention — insulin, food, timing, and vigilance. For the nearly 10 million people worldwide living with T1D, managing their health extends far beyond clinic visits or prescriptions. It takes place at kitchen tables, in school corridors, and in the decisions families make every day. Handling those daily decisions can be overwhelming, especially in many low- and middle-income countries (LMICs), where that burden is intensified by limited access…
July 28, 2026
In late June, the World Health Organization Regional Office for Africa (WHO AFRO) hosted the third International Conference on PEN-Plus in Africa (ICPPA) in Dar es Salaam, Tanzania. This year, African health leaders didn’t come to hear about a promising pilot. They came to talk about scaling it. The discussion shifted from proving PEN-Plus works to building the systems needed to sustain it.
June 25, 2026
Digestive Disease Week 2026 convened clinicians, researchers, and industry partners with the aim of accelerating the translation of new evidence into clinical practice, featuring key insights into inflammatory bowel disease (IBD). The meeting was held in Chicago, Illinois from May 2-5th, 2026 and Helmsley’s Crohn’s Disease Team was on hand to connect with grantees and other leaders in IBD.
May 19, 2026
Each year on May 19th, we unite with the global community to raise awareness for people with inflammatory bowel diseases (IBD), which includes Crohn’s disease. As in years past, this World IBD Day, the Helmsley Building in New York City is lit purple as a symbol of solidarity with patients who have IBD.
April 9, 2026
Every seven seconds, a woman or a baby dies from preventable complications during pregnancy, childbirth or in the first few weeks of life. Neonatal deaths now account for nearly half of all deaths among children under five, with over half occurring in sub-Saharan Africa. Maternal and newborn survival is one of the clearest reflections of the quality of care that…
March 26, 2026
Patricia “Patsy” Hudkins has watched the workplace video of her sudden cardiac arrest countless times, trying to find clues about what made that day different from any other shortly before her 39th birthday. One moment, she was reaching to get something for a customer at Finish Line Burgers & Brew in Velva, N.D. The next, she was dropping to the…
February 25, 2026
The 2026 Crohn’s and Colitis Congress convened clinicians, researchers, and industry partners with the aim to accelerate the translation of new evidence into clinical practice for inflammatory bowel disease (IBD) in Las Vegas, NV from January 22-24th, 2026. Crohn’s and Colitis Congress (CCCongress) offers opportunities for connection and collaboration — which we know are essential for success in driving research…